A method to assess soil erosion from smallholder farmers' fields: a case study from Malawi.

Soil erosion by water is a major threat to sustainable food production systems in Africa. This study presents a qualitative soil erosion assessment method that links the number of broken ridges (NBRS) observed on a smallholder farmer's field after a rain event to factors of soil erosion (e.g., rainfall intensity, slope steepness, crop canopy height, and conservation practice) and to soil loss data measured from a runoff plot and receiving small streams. The assessment method consists of a rapid survey of smallholder farmers combined with field monitoring. Results show an indirect relationship between NBRS and factors of soil erosion. Results also show a direct relationship between NBRS and suspended sediment concentrations measured from an experimental runoff plot and receiving streams that drain the sub-watersheds where farmers' fields are located. Given the limited human and financial resources available to soil erosion research in developing countries, monitoring NBRS is a simple, cost-effective, and reliable erosion assessment method for regions where smallholder farmers practice contour ridging.

Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapy.

Neutrophil-to-lymphocyte ratios (NLR) and eosinophil counts are associated with improved survival in melanoma patients treated with immune checkpoint inhibitors, but no study has investigated neutrophil-to-eosinophil ratios (NER) as a predictive indicator in this population. In this retrospective study evaluating anti-PD-1 treated patients with advanced melanoma, progression-free survival (PFS), overall survival (OS), objective response rates (ORR), and risk of high-grade (grade ≥3) immune-related adverse events (irAEs) were compared between groups defined by median pretreatment NLR and NER as well as median NLR and NER at 1-month post-treatment. Lower baseline NLR and NER were associated with improved OS [HR: 0.504, 95% CI: 0.328-0.773, p = .002 and HR: 0.442, 95% CI: 0.288-0.681, p < .001, respectively] on univariate testing. After accounting for multiple covariates, our multivariate analysis found that lower pretreatment NER was associated with better ORR (by irRECIST) (OR: 2.199, 95% CI: 1.071-4.582, p = .033) and improved OS (HR: 0.480, 95% CI: 0.296-0.777, p = .003). Baseline NLR, 1-month NLR, and 1-month NER were not associated with ORR, PFS, or OS outcomes; but 1-month NER correlated with lower risk of grade ≥3 irAEs (OR: 0.392, 95% CI: 0.165-0.895, p = .029). Our findings suggest baseline NER merits additional investigation as a novel prognostic marker for advanced melanoma patients receiving anti-PD-1-based regimens.